A Phase 3 Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
October 10, 2019
End Date
June 30, 2022
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
October 10, 2019
End Date
June 30, 2022